Shmuel Shoham

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. pmc Emerging fungal infections in solid organ transplant recipients
    Shmuel Shoham
    Transplant and Oncology Infectious Diseases Program, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Infect Dis Clin North Am 27:305-16. 2013
  2. pmc Impact of multidrug-resistant organisms on patients considered for lung transplantation
    Shmuel Shoham
    Transplant and Oncology Infectious Diseases Program, Johns Hopkins University School of Medicine, 1830 Baltimore, MD 21205, USA
    Infect Dis Clin North Am 27:343-58. 2013
  3. pmc Invasive fungal infections in solid organ transplant recipients
    Shmuel Shoham
    Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Future Microbiol 7:639-55. 2012
  4. pmc Diagnostic and therapeutic challenges in a liver transplant recipient with central nervous system invasive aspergillosis
    Dionissios Neofytos
    Division of Infectious Disease, The Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA
    Diagn Microbiol Infect Dis 73:374-5. 2012
  5. ncbi request reprint The pharmacology and clinical use of caspofungin
    William W Hope
    National Institutes of Health, 10 Center Dr, Bethesda, MD, 20892, USA
    Expert Opin Drug Metab Toxicol 3:263-74. 2007
  6. pmc Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection
    Robin K Avery
    1 Division of Infectious Diseases, Department of Medicine Johns Hopkins, Baltimore, MD 2 The Eudowood Division of Pediatric Infectious Diseases, Department of Pediatrics, Johns Hopkins, Baltimore, MD 3 Division of Nephrology, Department of Medicine, Johns Hopkins, Baltimore, MD 4 Department of Pharmacy, Johns Hopkins, Baltimore, MD 5 Division of Pulmonary and Critical Care, Department of Medicine Johns Hopkins, Baltimore, MD 6 The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD 7 Division of Medical Microbiology, Department of Pathology, Johns Hopkins, Baltimore, MD
    Transplantation 100:e74-80. 2016

Collaborators

Detail Information

Publications6

  1. pmc Emerging fungal infections in solid organ transplant recipients
    Shmuel Shoham
    Transplant and Oncology Infectious Diseases Program, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Infect Dis Clin North Am 27:305-16. 2013
    ..This article reviews the epidemiology, microbiology, and clinical impact of emerging fungal infections in solid organ transplant recipients, and provides up-to-date recommendations on their treatment...
  2. pmc Impact of multidrug-resistant organisms on patients considered for lung transplantation
    Shmuel Shoham
    Transplant and Oncology Infectious Diseases Program, Johns Hopkins University School of Medicine, 1830 Baltimore, MD 21205, USA
    Infect Dis Clin North Am 27:343-58. 2013
    ..The microbiology, epidemiology, clinical manifestations, and approach to these pathogens before transplant are reviewed in this article...
  3. pmc Invasive fungal infections in solid organ transplant recipients
    Shmuel Shoham
    Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Future Microbiol 7:639-55. 2012
    ..Within this context, we review recent advances in diagnostic modalities and antifungal chemotherapy, and their impact on evolving prophylaxis and treatment paradigms...
  4. pmc Diagnostic and therapeutic challenges in a liver transplant recipient with central nervous system invasive aspergillosis
    Dionissios Neofytos
    Division of Infectious Disease, The Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA
    Diagn Microbiol Infect Dis 73:374-5. 2012
    ....
  5. ncbi request reprint The pharmacology and clinical use of caspofungin
    William W Hope
    National Institutes of Health, 10 Center Dr, Bethesda, MD, 20892, USA
    Expert Opin Drug Metab Toxicol 3:263-74. 2007
    ....
  6. pmc Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection
    Robin K Avery
    1 Division of Infectious Diseases, Department of Medicine Johns Hopkins, Baltimore, MD 2 The Eudowood Division of Pediatric Infectious Diseases, Department of Pediatrics, Johns Hopkins, Baltimore, MD 3 Division of Nephrology, Department of Medicine, Johns Hopkins, Baltimore, MD 4 Department of Pharmacy, Johns Hopkins, Baltimore, MD 5 Division of Pulmonary and Critical Care, Department of Medicine Johns Hopkins, Baltimore, MD 6 The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD 7 Division of Medical Microbiology, Department of Pathology, Johns Hopkins, Baltimore, MD
    Transplantation 100:e74-80. 2016
    ..Several investigational anti-CMV agents are under development, but more information is needed on outcomes of current treatments to facilitate clinical trial design for new drugs...